Grace Therapeutics, Inc. · NASDAQ:GRCE

Opaleye Management Inc. bought 15,089 Grace Therapeutics, Inc. shares (Form 4)

Traded Sep 21 to Sep 23, 2026 · Filed Sep 23, 2026

From Sep 21 to Sep 23, 2026, Opaleye Management Inc. (10% owner) bought 15,089 Grace Therapeutics, Inc. shares at US$2.10 for US$31,687, leaving 2,855,318 shares. Filed Sep 23, 2026 (Form 4).

Bought
15,089 shares
Price
US$2.10
Value
US$31,687
Holding after
2,855,318 shares (held indirectly)
Trading plan
No
Role
10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 21, 2026Common Stock, par value $0.0001 per shareBuy9,771US$2.102,850,000Indirect
Sep 23, 2026Common Stock, par value $0.0001 per shareBuy5,318US$2.102,855,318Indirect

Source

View original at SEC

Related